BDRX: Biodexa Pharmaceuticals Plc Financial Statements

Balance sheet, income statement, and cash flow statements for Biodexa Pharmaceuticals Plc (BDRX).

OverviewDividends

$1.47M Market Cap.

As of 07/31/2025 5:00 PM ET (MRY) • Disclaimer

BDRX Market Cap. (MRY)


BDRX Shares Outstanding (MRY)


BDRX Assets (MRY)


Total Assets

$14.78M

Total Liabilities

$6.46M

Total Investments

$0

BDRX Income (MRY)


Revenue

$0

Net Income

-$5.73M

Operating Expense

$9.20M

BDRX Cash Flow (MRY)


CF Operations

-$12.39M

CF Investing

-$598.00K

CF Financing

$8.56M

BDRX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$14,780,000 (40.20%)

$10,542,000 (90.81%)

$5,525,000 (-57.21%)

$12,913,000 (31.54%)

Assets Current

$8,810,000 (25.32%)

$7,030,000 (49.96%)

$4,688,000 (-60.14%)

$11,761,000 (26.80%)

Assets Non-Current

$5,970,000 (69.99%)

$3,512,000 (319.59%)

$837,000 (-27.34%)

$1,152,000 (112.55%)

Goodwill & Intangible Assets

$5,646,000 (91.98%)

$2,941,000 (48916.67%)

$6,000 (0%)

$0 (0%)

Shareholders Equity

$8,322,000 (77.90%)

$4,678,000 (47.94%)

$3,162,000 (-69.75%)

$10,452,000 (55.58%)

Property Plant & Equipment Net

$324,000 (-43.26%)

$571,000 (-31.29%)

$831,000 (-27.86%)

$1,152,000 (112.55%)

Cash & Equivalents

$1,669,000 (-72.05%)

$5,971,000 (110.54%)

$2,836,000 (-71.80%)

$10,057,000 (33.28%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$6,568,000 (931.08%)

$637,000 (-36.68%)

$1,006,000 (-2.71%)

$1,034,000 (80.77%)

Trade & Non-Trade Payables

$3,504,000 (182.58%)

$1,240,000 (-14.31%)

$1,447,000 (32.51%)

$1,092,000 (-11.22%)

Accumulated Retained Earnings (Deficit)

-$150,424,000 (-3.91%)

-$144,767,000 (-6.97%)

-$135,336,000 (-5.89%)

-$127,803,000 (-4.39%)

Tax Assets

$573,000 (35.78%)

$422,000 (-50.12%)

$846,000 (26.27%)

$670,000 (-42.09%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$727,000 (56.68%)

$464,000 (-25.64%)

$624,000 (-18.54%)

$766,000 (194.62%)

Debt Current

$609,000 (260.36%)

$169,000 (4.97%)

$161,000 (10.27%)

$146,000 (-27.00%)

Debt Non-Current

$118,000 (-60.00%)

$295,000 (-36.29%)

$463,000 (-25.32%)

$620,000 (933.33%)

Total Liabilities

$6,458,000 (10.13%)

$5,864,000 (148.16%)

$2,363,000 (-3.98%)

$2,461,000 (-20.59%)

Liabilities Current

$5,034,000 (-9.61%)

$5,569,000 (193.11%)

$1,900,000 (3.20%)

$1,841,000 (-38.41%)

Liabilities Non-Current

$1,424,000 (382.71%)

$295,000 (-36.29%)

$463,000 (-25.32%)

$620,000 (463.64%)

BDRX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$381,000 (-45.49%)

$699,000 (20.93%)

$578,000 (68.51%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$3,793,000 (-12.64%)

$4,342,000 (-4.40%)

$4,542,000 (54.18%)

$2,946,000 (-40.58%)

Research & Development Expense

$5,437,000 (33.69%)

$4,067,000 (-20.43%)

$5,111,000 (9.82%)

$4,654,000 (-23.30%)

Operating Expenses

$9,199,000 (9.58%)

$8,395,000 (-12.83%)

$9,631,000 (27.13%)

$7,576,000 (-67.60%)

Interest Expense

$165,000 (302.44%)

$41,000 (-22.64%)

$53,000 (20.45%)

$44,000 (-89.79%)

Income Tax Expense

-$250,000 (38.42%)

-$406,000 (51.20%)

-$832,000 (-28.79%)

-$646,000 (49.57%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$5,729,000 (19.07%)

-$7,079,000 (7.54%)

-$7,656,000 (-40.22%)

-$5,460,000 (75.39%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$5,729,000 (19.07%)

-$7,079,000 (7.54%)

-$7,656,000 (-40.22%)

-$5,460,000 (75.39%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$5,729,000 (19.07%)

-$7,079,000 (7.54%)

-$7,656,000 (-40.22%)

-$5,460,000 (75.39%)

Weighted Average Shares

$3,626,112,922 (1204.49%)

$277,971,722 (5544.47%)

$4,924,671 (56.16%)

$3,153,693 (131.18%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

-$5,814,000 (21.90%)

-$7,444,000 (11.75%)

-$8,435,000 (-39.15%)

-$6,062,000 (73.69%)

Gross Profit

$0 (0%)

$381,000 (-45.49%)

$699,000 (20.93%)

$578,000 (68.51%)

Operating Income

-$9,199,000 (-14.79%)

-$8,014,000 (10.28%)

-$8,932,000 (-27.64%)

-$6,998,000 (69.63%)

BDRX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$598,000 (-125.66%)

-$265,000 (-20.45%)

-$220,000 (20.86%)

-$278,000 (-110.80%)

Net Cash Flow from Financing

$8,557,000 (-16.32%)

$10,226,000 (21657.45%)

$47,000 (-99.47%)

$8,805,000 (185.51%)

Net Cash Flow from Operations

-$12,390,000 (-61.52%)

-$7,671,000 (0.71%)

-$7,726,000 (-7.83%)

-$7,165,000 (36.34%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,302,000 (-237.22%)

$3,135,000 (143.42%)

-$7,221,000 (-386.66%)

$2,519,000 (169.15%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

-$79,000 (61.84%)

-$207,000 (0%)

$0 (0%)

Capital Expenditure

-$774,000 (-198.84%)

-$259,000 (-516.67%)

-$42,000 (84.89%)

-$278,000 (-321.21%)

Issuance (Repayment) of Debt Securities

$245,000 (230.32%)

-$188,000 (-5.62%)

-$178,000 (17.21%)

-$215,000 (96.66%)

Issuance (Purchase) of Equity Shares

$8,312,000 (-20.28%)

$10,427,000 (4190.95%)

$243,000 (-97.31%)

$9,035,000 (-7.26%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0

-

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

-$8,000 (-103.07%)

Share Based Compensation

$283,000 (910.71%)

$28,000 (-77.24%)

$123,000 (38.20%)

$89,000 (122.03%)

Depreciation Amortization & Accretion

$252,000 (-10.00%)

$280,000 (-17.65%)

$340,000 (-15.63%)

$403,000 (-66.61%)

BDRX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-

-1858.00% (-69.63%)

-1095.30% (-15.95%)

-944.60% (85.40%)

EBITDA Margin

-

-1880.30% (-62.36%)

-1158.10% (-18.28%)

-979.10% (84.62%)

Return on Average Equity (ROAE)

-88.10% (51.22%)

-180.60% (-60.53%)

-112.50% (-76.89%)

-63.60% (62.34%)

Return on Average Assets (ROAA)

-45.20% (48.69%)

-88.10% (-6.14%)

-83.00% (-72.92%)

-48.00% (55.96%)

Return on Sales (ROS)

-

-1953.80% (-61.91%)

-1206.70% (-15.06%)

-1048.80% (84.39%)

Return on Invested Capital (ROIC)

3668.10% (409.53%)

719.90% (236.04%)

-529.20% (42.25%)

-916.40% (-50.06%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-32.4 (-22.43%)

-26.46 (37.28%)

-42.2 (-1721.93%)

-2.32 (95.61%)

Price to Sales Ratio (P/S)

-

3.86 (-16.19%)

4.61 (-73.19%)

17.19 (-20.86%)

Price to Book Ratio (P/B)

0.14 (-55.24%)

0.32 (-69.09%)

1.02 (7.26%)

0.95 (-14.34%)

Debt to Equity Ratio (D/E)

0.78 (-38.12%)

1.25 (67.87%)

0.75 (217.87%)

0.23 (-49.02%)

Earnings Per Share (EPS)

-1 (95.00%)

-20 (98.71%)

-1,550 (98.86%)

-136,000 (-1212.74%)

Sales Per Share (SPS)

0 (0%)

173.5 (-98.99%)

17,101.01 (-30.02%)

24,436.96 (-29.05%)

Free Cash Flow Per Share (FCFPS)

-363.03 (87.27%)

-2,852.81 (98.19%)

-157,736.44 (33.17%)

-236,009.05 (71.56%)

Book Value Per Share (BVPS)

229.5 (-86.36%)

1,682.9 (-97.38%)

64,207.34 (-80.63%)

331,421.01 (-32.70%)

Tangible Assets Book Value Per Share (TABVPS)

251.9 (-90.79%)

2,734.45 (-97.56%)

112,068.41 (-72.63%)

409,456.52 (-43.10%)

Enterprise Value Over EBIT (EV/EBIT)

1 (0%)

0 (0%)

0 (0%)

-1 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.67 (61.39%)

0.42 (56.18%)

0.27 (123.61%)

-1.13 (-269.61%)

Asset Turnover

0 (0%)

0.05 (-38.16%)

0.08 (49.02%)

0.05 (200.00%)

Current Ratio

1.75 (38.67%)

1.26 (-48.84%)

2.47 (-61.38%)

6.39 (105.87%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$13,164,000 (-66.00%)

-$7,930,000 (-2.09%)

-$7,768,000 (-4.37%)

-$7,443,000 (34.25%)

Enterprise Value (EV)

-$4,680,108 (-23.82%)

-$3,779,758 (-44.93%)

-$2,607,996 (-130.56%)

$8,534,398 (-6.69%)

Earnings Before Tax (EBT)

-$5,979,000 (20.12%)

-$7,485,000 (11.82%)

-$8,488,000 (-39.01%)

-$6,106,000 (73.98%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$5,562,000 (22.36%)

-$7,164,000 (11.50%)

-$8,095,000 (-43.05%)

-$5,659,000 (74.08%)

Invested Capital

$3,158,000 (190.88%)

-$3,475,000 (-346.98%)

$1,407,000 (-21.00%)

$1,781,000 (488.86%)

Working Capital

$3,776,000 (158.45%)

$1,461,000 (-47.60%)

$2,788,000 (-71.90%)

$9,920,000 (57.81%)

Tangible Asset Value

$9,134,000 (20.17%)

$7,601,000 (37.72%)

$5,519,000 (-57.26%)

$12,913,000 (31.54%)

Market Capitalization

$1,468,576 (-21.15%)

$1,862,411 (-52.01%)

$3,880,640 (-70.70%)

$13,245,509 (29.81%)

Average Equity

$6,500,000 (65.82%)

$3,920,000 (-42.41%)

$6,807,000 (-20.71%)

$8,585,000 (-34.66%)

Average Assets

$12,661,000 (57.60%)

$8,033,500 (-12.86%)

$9,219,000 (-18.88%)

$11,365,000 (-44.17%)

Invested Capital Average

-$158,500 (84.67%)

-$1,034,000 (-164.87%)

$1,594,000 (140.97%)

$661,500 (-82.47%)

Shares

3,626,112,922 (1204.49%)

277,971,722 (5544.47%)

4,924,671 (56.16%)

3,153,693 (131.18%)